Table 5.
How respondents’ prescribing practices have changed because of pandemic-related restrictions
| Criteria | Scale of change | n (%) |
|---|---|---|
| Antipsychotic prescribing | ||
| Increased | 65 (46.8) | |
| No change | 44 (31.7) | |
| Decreased | 1 (0.7) | |
| Missing data | 29 (20.9) | |
| Antidepressant prescribing | ||
| Increased | 61 (43.9) | |
| No change | 46 (33.1) | |
| Decreased | 0 (0) | |
| Missing data | 32 (23) | |
| Mood stabiliser prescribing | ||
| Increased | 42 (30.2) | |
| No change | 64 (46) | |
| Decreased | 1 (0.7) | |
| Missing data | 32 (77) | |
| Benzodiazepine prescribing | ||
| Increased | 35 (25.2) | |
| No change | 70 (50.4) | |
| Decreased | 3 (2.2) | |
| Missing data | 31 (22.3) | |
| Stimulant prescribing | ||
| Increased | 14 (10.1) | |
| No change | 87 (62.6) | |
| Decreased | 5 (3.6) | |
| Missing data | 33 (23.7) | |
| Pain medication prescribing | ||
| Increased | 10 (7.2) | |
| No change | 97 (69.8) | |
| Decreased | 0 (0) | |
| Missing data | 32 (23) | |
| Physical health medication prescribing | ||
| Increased | 64 (46) | |
| No change | 41 (29.5) | |
| Decreased | 3 (2.2) | |
| Missing data | 31 (22.3) | |